Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bellerophon Therapeutics Inc
BLPH
Healthcare
Biotechnology
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company’s focus is to develop its nitric oxide therapy for patients with pulmonary hypertension (PH) using its delivery system, INOpulse. The Company’s INOpulse program is an...
extension of the technology used in hospitals to deliver continuous flow inhaled nitric oxide. INOpulse program is built on scientific and technical development for the therapeutic delivery of inhaled nitric oxide. It is also developing INOpulse for the treatment of patients with fibrotic interstitial lung disease (fILD), PH-Sarcoidosis, PH-chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other pulmonary hypertension conditions. The Company’s subsidiaries include Bellerophon BCM LLC, Bellerophon Pulse Technologies LLC and Bellerophon Services, Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:BLPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Nov 15, 2023 10:48am
Update?
So I wonder if there is anything left of the company and product potential??
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 31, 2023 8:30am
New Press Release - Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023Signed License Agreement with Baylor BioSciences to Commercialize INOpulse® in Greater ChinaStrengthened Balance Sheet Through $5 Million Registered Direct Offering with Life Sciences-focused...
read article.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 21, 2023 11:37am
BLPH...... Dead !
Say Good night ..... vols are all but gone !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 2:58pm
BLPH...... Hurry up & Die !!!!!
Zero rev
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 12:15pm
BLPH....this is the end....my only friend The End
Watch out below ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 10:11am
BLPH..... I call this manip.....
"Walkin the Dog" !!! Ya never know how high they will take it ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2023 9:56am
BLPH.....Simply amazing what "The Pros" can manip
This will implode......maybe ; ) Now trading at $7.20 JMHO
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 08, 2023 2:51pm
RE:BLPH..... P.O announced...sh price up?
BLPH.....$7.34 now.... Sheesh .U seldom see share prices rise whe a P.O is announced.....I should have held my position Always learning how this system operates
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 11:58am
BLPH..... N.H.O.D..... $4.17
Cha Ching !!!!!
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 10:50am
BLPH....not too bags ; )
$2.50 now
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 06, 2023 8:36am
BLPH..... P.O announced...sh price up?
Bellerophon Therapeutics Announces $5 Million Registered Direct Offering 2023-03-06 05:30 ET - News Release WARREN, N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Bellerophon
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Feb 09, 2023 9:16am
Bellerophon Therapeutics Receives IND Clearance from China
Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease China NPMA accepts the use of
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Jan 05, 2023 10:34am
Bellerophon stock rockets +100%
Bellerophon stock rockets +100% on a license and commercialization deal in China https://seekingalpha.com/news/3922338-bellerophon-stock-rockets-100-on-a-license-and-commercialization-deal-in
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Oct 01, 2022 11:04am
Bellerophon Announces FDA Acceptance
Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease BLPH | 4 days ago
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Comment by
Red~One
on Oct 01, 2022 10:41am
RE:BLPH......Cheaper than a Large Slurpee ; )
What is that about a reverse split? Have they said that they want one?
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income